Please enable JavaScript to continue using this application.

Compare $JANX vs $MNKD | Chartloom

Compare

$JANX vs $MNKD

Janux Therapeutics Inc · MannKind Corp

JANX

Janux Therapeutics Inc

MNKD

MannKind Corp

Compare $JANX vs $MNKD

Comparing Janux Therapeutics Inc and MannKind Corp

JANXJanux Therapeutics Inc

MNKDMannKind Corp

JANXJanux Therapeutics Inc

Market cap

$1.12B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

63.26x

Rev growth (TTM)

5367.0%

YTD performance

34.7%

52W performance

-24.0%

FCF yield

-3.7%

MNKDMannKind Corp

Market cap

$1.05B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.01x

Rev growth (TTM)

30.5%

YTD performance

-41.3%

52W performance

-39.5%

FCF yield

-1.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

JANX

MNKD

Detailed metrics comparison

JANX

Janux Therapeutics Inc

MNKD

MannKind Corp

Market Cap

JANX$1.12B

MNKD$1.05B

Enterprise Value

JANX$1.09B

MNKD$1.57B

Price

JANX$18.39

MNKD$3.29

P/E Ratio

JANXN/A

MNKDN/A

P/S Ratio

JANX46.73x

MNKD2.67x

EV/Sales

JANX45.57x

MNKD3.98x

EV/EBITDA

JANX0.00x

MNKD43.92x

P/B Ratio

JANX1.12x

MNKD69.42x

P/FCF Ratio

JANXN/A

MNKDN/A

EV/FCF

JANX-26.09x

MNKD-86.45x

PEG Ratio

JANXN/A

MNKDN/A

Forward P/E (NTM)

JANXN/A

MNKDN/A

Forward P/S (NTM)

JANX63.26x

MNKD2.01x

Revenue (TTM)

JANX$24M

MNKD$394M

Revenue Growth (YoY)

JANX5367.0%

MNKD30.5%

Forward Rev Growth

JANX-76.0%

MNKD13.7%

Gross Margin (TTM)

JANX0.0%

MNKD76.8%

Operating Margin (TTM)

JANX0.0%

MNKD2.3%

EBITDA Margin (TTM)

JANX-590.2%

MNKD8.7%

Net Margin (TTM)

JANX-427.5%

MNKD-10.9%

FCF Margin (TTM)

JANX-174.7%

MNKD-4.6%

Net Income (TTM)

JANX$-103M

MNKD$-43M

FCF (TTM)

JANX$-42M

MNKD$-18M

EPS (TTM)

JANX-$1.63

MNKD-$0.14

ROE (TTM)

JANX-1079.0%

MNKD-29771.0%

ROA (TTM)

JANX-1010.0%

MNKD-619.0%

ROIC (TTM)

JANX-1079.0%

MNKD-2719.0%

Cash

JANX$28M

MNKD$53M

Debt

JANX$0

MNKD$570M

Net Cash/Debt

JANX$28M

MNKD$-517M

Current Ratio (TTM)

JANX16.35x

MNKD1.72x

Quick Ratio (TTM)

JANX16.25x

MNKD1.29x

Debt/Equity (TTM)

JANX0.00x

MNKD9.95x

Debt/Assets (TTM)

JANX0.0%

MNKD0.0%

Interest Coverage (TTM)

JANXN/A

MNKDN/A

Net Debt/EBITDA (TTM)

JANX0.00x

MNKD0.00x

Beta

JANX2.42

MNKD1.09

52W Performance

JANX-24.0%

MNKD-39.5%

YTD Performance

JANX34.7%

MNKD-41.3%

% from 52W High

JANX-48.0%

MNKD-49.5%

% from 52W Low

JANX51.7%

MNKD47.5%

Asset Turnover (TTM)

JANX0.02x

MNKD0.57x

FCF Yield (TTM)

JANX-3.7%

MNKD-1.7%

Earnings Yield (TTM)

JANX-9.1%

MNKD-4.1%

Dividend Yield (TTM)

JANXN/A

MNKDN/A

Rule of 40

JANX5,192.3

MNKD25.8

EV/GP/RG

JANXN/A

MNKD0.15

Ticker research

View JANX research View MNKD research

Metric	JANX Janux Therapeutics Inc	MNKD MannKind Corp
Market & Valuation
Market Cap	$1.12B	$1.05B
Enterprise Value	$1.09B	$1.57B
Price	$18.39	$3.29
P/E Ratio	N/A	N/A
P/S Ratio	46.73x	2.67x
EV/Sales	45.57x	3.98x
EV/EBITDA	0.00x	43.92x
P/B Ratio	1.12x	69.42x
P/FCF Ratio	N/A	N/A
EV/FCF	-26.09x	-86.45x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	63.26x	2.01x
Revenue & Growth
Revenue (TTM)	$24M	$394M
Revenue Growth (YoY)	5367.0%	30.5%
Forward Rev Growth	-76.0%	13.7%
Profitability
Gross Margin (TTM)	0.0%	76.8%
Operating Margin (TTM)	0.0%	2.3%
EBITDA Margin (TTM)	-590.2%	8.7%
Net Margin (TTM)	-427.5%	-10.9%
FCF Margin (TTM)	-174.7%	-4.6%
Net Income (TTM)	$-103M	$-43M
FCF (TTM)	$-42M	$-18M
EPS (TTM)	-$1.63	-$0.14
ROE (TTM)	-1079.0%	-29771.0%
ROA (TTM)	-1010.0%	-619.0%
ROIC (TTM)	-1079.0%	-2719.0%
Financial Health
Cash	$28M	$53M
Debt	$0	$570M
Net Cash/Debt	$28M	$-517M
Current Ratio (TTM)	16.35x	1.72x
Quick Ratio (TTM)	16.25x	1.29x
Debt/Equity (TTM)	0.00x	9.95x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.42	1.09
52W Performance	-24.0%	-39.5%
YTD Performance	34.7%	-41.3%
% from 52W High	-48.0%	-49.5%
% from 52W Low	51.7%	47.5%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.57x
FCF Yield (TTM)	-3.7%	-1.7%
Earnings Yield (TTM)	-9.1%	-4.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5,192.3	25.8
EV/GP/RG	N/A	0.15
Ticker research	View JANX research	View MNKD research

Valuation

P/S Ratio

MNKD

2.67x

JANX

46.73x

EV/FCF

MNKD

-86.45x

JANX

-26.09x

Growth & revenue

Revenue Growth TTM

JANX

5367.0%

MNKD

30.5%

Forward Revenue Growth

MNKD

13.7%

JANX

-76.0%

Profitability & performance

Gross Margin

MNKD

76.8%

JANX

0.0%

ROE

JANX

-1079.0%

MNKD

-29771.0%

FCF Yield %

MNKD

-1.7%

JANX

-3.7%

52-Week Performance

JANX

-24.0%

MNKD

-39.5%

Detailed metrics comparison

JANX

Janux Therapeutics Inc

MNKD

MannKind Corp

Market Cap

JANX$1.12B

MNKD$1.05B

Enterprise Value

JANX$1.09B

MNKD$1.57B

Price

JANX$18.39

MNKD$3.29

P/E Ratio

JANXN/A

MNKDN/A

P/S Ratio

JANX46.73x

MNKD2.67x

EV/Sales

JANX45.57x

MNKD3.98x

EV/EBITDA

JANX0.00x

MNKD43.92x

P/B Ratio

JANX1.12x

MNKD69.42x

P/FCF Ratio

JANXN/A

MNKDN/A

EV/FCF

JANX-26.09x

MNKD-86.45x

PEG Ratio

JANXN/A

MNKDN/A

Forward P/E (NTM)

JANXN/A

MNKDN/A

Forward P/S (NTM)

JANX63.26x

MNKD2.01x

Revenue (TTM)

JANX$24M

MNKD$394M

Revenue Growth (YoY)

JANX5367.0%

MNKD30.5%

Forward Rev Growth

JANX-76.0%

MNKD13.7%

Gross Margin (TTM)

JANX0.0%

MNKD76.8%

Operating Margin (TTM)

JANX0.0%

MNKD2.3%

EBITDA Margin (TTM)

JANX-590.2%

MNKD8.7%

Net Margin (TTM)

JANX-427.5%

MNKD-10.9%

FCF Margin (TTM)

JANX-174.7%

MNKD-4.6%

Net Income (TTM)

JANX$-103M

MNKD$-43M

FCF (TTM)

JANX$-42M

MNKD$-18M

EPS (TTM)

JANX-$1.63

MNKD-$0.14

ROE (TTM)

JANX-1079.0%

MNKD-29771.0%

ROA (TTM)

JANX-1010.0%

MNKD-619.0%

ROIC (TTM)

JANX-1079.0%

MNKD-2719.0%

Cash

JANX$28M

MNKD$53M

Debt

JANX$0

MNKD$570M

Net Cash/Debt

JANX$28M

MNKD$-517M

Current Ratio (TTM)

JANX16.35x

MNKD1.72x

Quick Ratio (TTM)

JANX16.25x

MNKD1.29x

Debt/Equity (TTM)

JANX0.00x

MNKD9.95x

Debt/Assets (TTM)

JANX0.0%

MNKD0.0%

Interest Coverage (TTM)

JANXN/A

MNKDN/A

Net Debt/EBITDA (TTM)

JANX0.00x

MNKD0.00x

Beta

JANX2.42

MNKD1.09

52W Performance

JANX-24.0%

MNKD-39.5%

YTD Performance

JANX34.7%

MNKD-41.3%

% from 52W High

JANX-48.0%

MNKD-49.5%

% from 52W Low

JANX51.7%

MNKD47.5%

Asset Turnover (TTM)

JANX0.02x

MNKD0.57x

FCF Yield (TTM)

JANX-3.7%

MNKD-1.7%

Earnings Yield (TTM)

JANX-9.1%

MNKD-4.1%

Dividend Yield (TTM)

JANXN/A

MNKDN/A

Rule of 40

JANX5,192.3

MNKD25.8

EV/GP/RG

JANXN/A

MNKD0.15

Ticker research

View JANX research View MNKD research

Metric	JANX Janux Therapeutics Inc	MNKD MannKind Corp
Market & Valuation
Market Cap	$1.12B	$1.05B
Enterprise Value	$1.09B	$1.57B
Price	$18.39	$3.29
P/E Ratio	N/A	N/A
P/S Ratio	46.73x	2.67x
EV/Sales	45.57x	3.98x
EV/EBITDA	0.00x	43.92x
P/B Ratio	1.12x	69.42x
P/FCF Ratio	N/A	N/A
EV/FCF	-26.09x	-86.45x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	63.26x	2.01x
Revenue & Growth
Revenue (TTM)	$24M	$394M
Revenue Growth (YoY)	5367.0%	30.5%
Forward Rev Growth	-76.0%	13.7%
Profitability
Gross Margin (TTM)	0.0%	76.8%
Operating Margin (TTM)	0.0%	2.3%
EBITDA Margin (TTM)	-590.2%	8.7%
Net Margin (TTM)	-427.5%	-10.9%
FCF Margin (TTM)	-174.7%	-4.6%
Net Income (TTM)	$-103M	$-43M
FCF (TTM)	$-42M	$-18M
EPS (TTM)	-$1.63	-$0.14
ROE (TTM)	-1079.0%	-29771.0%
ROA (TTM)	-1010.0%	-619.0%
ROIC (TTM)	-1079.0%	-2719.0%
Financial Health
Cash	$28M	$53M
Debt	$0	$570M
Net Cash/Debt	$28M	$-517M
Current Ratio (TTM)	16.35x	1.72x
Quick Ratio (TTM)	16.25x	1.29x
Debt/Equity (TTM)	0.00x	9.95x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.42	1.09
52W Performance	-24.0%	-39.5%
YTD Performance	34.7%	-41.3%
% from 52W High	-48.0%	-49.5%
% from 52W Low	51.7%	47.5%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.57x
FCF Yield (TTM)	-3.7%	-1.7%
Earnings Yield (TTM)	-9.1%	-4.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5,192.3	25.8
EV/GP/RG	N/A	0.15
Ticker research	View JANX research	View MNKD research